Axar.az
UP

Axar.Az Logo

Moderna begins study of COVID vaccine in young kids

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Moderna has begun testing its COVID-19 vaccine on young children, the company announced Tuesday.

Axar.az reports that the study, called KidCOVE, is testing Moderna's vaccine candidate in children ages 6 months to less than 12 years old.

"It is humbling to know that 53 million doses have been administered to people in the U.S.," Stéphane Bancel, chief executive officer of Moderna, said in a statement. "We are encouraged by the primary analysis of the Phase 3 COVE study of mRNA-1273 in adults ages 18 and above and this pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population."

Date
2021.03.16 / 22:15
Author
Axar.az
Comments
See also

WHO records over 517,000 new daily cases of COVID-19

WHO statement on "vaccination passport"

100M Americans received at least one vaccine dose

Yemen gets first COVID-19 vaccines

Number of COVID-19 cases across globe up by over 518,000

WHO records over 612,000 new daily cases of COVID-19

Britain nearing vaccine deal with European Union - The Times

WHO: The acute phase of the pandemic continues

The death toll is rising, the WHO said

Number of COVID-19 cases across globe up by over 461,000

Latest
 
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla